CLINICAL_TRIALS
research
· 2024-10-08
Clinical Trial Update: Percutaneous Gelled Alcohol Sclerotherapy for Aggressive Angiomas: Evaluation of Feasibility, Safety, and Efficacy
Summary
This clinical trial update describes a study evaluating percutaneous gelled alcohol sclerotherapy for aggressive bone angiomas, focusing on feasibility, safety,…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Bone Angioma | Status: RECRUITING